Faculty scores uniformly outstanding results in 2015 Excellence in Research for Australia (ERA) Assessment
The Faculty of Pharmacy and Pharmaceutical Sciences has achieved an outstanding result in the latest round of Excellence in Research for Australia (ERA) rankings. ERA independently assesses the quality of research conducted in Australia's higher education institutions. It provides an international benchmark to measure both research quality and environment, as well as discipline expertise.
The Faculty achieved the highest possible score of "5" (well above world standard) in all its major research discipline areas, including:
- Medicinal and Biomolecular Chemistry
- Pharmacology and Pharmaceutical Sciences
Across the University, Monash was eligible for assessment in 92 disciplines and of these, 38 were awarded the highest possible rating of 5, including – Macromolecular and Materials Chemistry, Physical Chemistry, Nanotechnology, Clinical Sciences, Neurosciences, and Chemical Engineering all of which were contributed to with research publications from the Faculty.
Overall, the quality of Monash research noted a marked improvement with 88% of submitted disciplines across the University judged as being "above world standard" (score of 4) or "well above world standard" (highest possible score of 5). This compares with 67% in ERA 2012 and 57% in ERA 2010.
Dean of the Faculty of Pharmacy and Pharmaceutical Science Professor Bill Charman said the results for the faculty are a perfect set of numbers reflecting the integrity, quality and impact of our research.
"The results of the latest ERA round are indicative of our commitment to continuous improvement and our strength in producing research that addresses real world issues," Professor Charman said.
The significant improvements in ERA ratings follows on from Monash achieving its best ever result in the Academic Ranking of World Universities, compiled by Shanghai Jiao Tong University and ranking 73 in the Times Higher Education World University Rankings.